[Fluorandrenolone for the local therapy of various dermatoses, including psoriasis vulgaris].
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002056:Burns / Q000188:drug therapy; D002908:Chronic Disease; D003872:Dermatitis / Q000188:drug therapy; D003877:Dermatitis, Contact / Q000188:drug therapy; D012628:Dermatitis, Seborrheic / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy; D004485:Eczema / Q000188:drug therapy; D005260:Female; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone; D007871:Leg Ulcer / Q000188:drug therapy; D008010:Lichen Planus / Q000188:drug therapy; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy; D008297:Male; D009450:Neurodermatitis / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D011855:Radiodermatitis / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D006854:Hydrocortisone
Fluorandrenolon zur lokalen Therapie verschiedener Dermatosen, einschliesslich der Psoriasis vulgaris.